Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Free Report) was the recipient of a significant increase in short interest in August. As of August 15th, there was short interest totalling 1,320,000 shares, an increase of 150.1% from the July 31st total of 527,700 shares. Currently, 5.9% of the shares of the stock are sold short. Based […]
Eton Pharmaceuticals (NASDAQ:ETON – Get Free Report) is set to release its earnings data after the market closes on Thursday, August 10th. Analysts expect Eton Pharmaceuticals to post earnings of ($0.09) per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link. Eton Pharmaceuticals […]
Eton Pharmaceuticals (NASDAQ:ETON – Free Report) had its price objective trimmed by HC Wainwright from $10.00 to $9.00 in a research note issued to investors on Monday, The Fly reports. HC Wainwright also issued estimates for Eton Pharmaceuticals’ Q2 2024 earnings at $0.02 EPS, Q3 2024 earnings at $0.03 EPS, Q4 2024 earnings at $0.06 […]
Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Rating) was the target of a significant decline in short interest in May. As of May 15th, there was short interest totalling 530,400 shares, a decline of 9.7% from the April 30th total of 587,500 shares. Approximately 2.4% of the shares of the stock are sold short. Based on […]
Opaleye Management Inc. lowered its stake in shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Rating) by 13.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,170,000 shares of the company’s stock after selling 351,000 shares during the quarter. Eton Pharmaceuticals […]